Andesa Financial Management’s AbbVie ABBV Stock Holding History

Andesa Financial Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$919K	Buy	5,926 +845	+17%	+$129K	0.47%	56
2022 Q4	$821K	Sell	5,081 -396	-7%	-$60.7K	0.45%	62
2022 Q3	$735K	Buy	5,477 +735	+15%	+$105K	0.26%	76
2022 Q2	$726K	Buy	4,742 +341	+8%	+$52.1K	0.46%	59
2022 Q1	$716K	Sell	4,401 -785	-15%	-$114K	0.39%	62
2021 Q4	$702K	Buy	5,186 +327	+7%	+$38.6K	0.34%	68
2021 Q3	$522K	Buy	4,859 +617	+15%	+$70.5K	0.28%	82
2021 Q2	$477K	Sell	4,242 -438	-9%	-$49.3K	0.14%	98
2021 Q1	$506K	Buy	4,680 +65	+1%	+$6.95K	0.16%	91
2020 Q4	$496K	Buy	4,615 +164	+4%	+$15.8K	0.33%	71
2020 Q3	$390K	Buy	4,451 +1,722	+63%	+$162K	0.16%	101
2020 Q2	$268K	Buy	+2,729	New	+$240K	0.24%	88
2019 Q3	–	Sell	-5,295	Closed	-$385K	–	103
2019 Q2	$385K	Sell	5,295 -50,485	-91%	-$3.97M	0.36%	64
2019 Q1	$4.49M	Buy	55,780 +33,101	+146%	+$2.71M	2.21%	17
2018 Q4	$2.09M	Buy	22,679 +13,589	+149%	+$1.2M	2.49%	13
2018 Q3	$857K	Sell	9,090 -13,609	-60%	-$1.29M	1.32%	31
2018 Q2	$2.1M	Buy	22,699 +220	+1%	+$21.5K	3.39%	7
2018 Q1	$2.13M	Sell	22,479 -988	-4%	-$109K	3.52%	7
2017 Q4	$2.27M	Buy	+23,467	New	+$2.21M	3.36%	5

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Andesa Financial Management's ABBV Position: Q1 2023 in Review

Andesa Financial Management increased its AbbVie (ABBV) stake by 17% in Q1 2023, buying an estimated $129K and bringing the position to 5,926 shares worth $919K. The position accounts for 0.47% of the portfolio, ranked #56.

Andesa Financial Management first reported a position in ABBV in Q4 2017 and has held it in 19 quarters since. The position peaked at $4.49M in Q1 2019. 3,138 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

Andesa Financial Management held 5,926 shares of AbbVie worth $919K as of Q1 2023.
Andesa Financial Management bought 845 AbbVie shares in Q1 2023, an estimated $129K.
AbbVie made up 0.47% of Andesa Financial Management's portfolio in Q1 2023, its #56 holding.
Andesa Financial Management first reported a position in AbbVie in Q4 2017 and has held it in 19 quarters since.
Andesa Financial Management's AbbVie position peaked at $4.49M in Q1 2019.
3,138 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on Andesa Financial Management's 13F filing for Q1 2023, filed 5 May 2023.